Open Government Portal

About this information

Open data is defined as structured data that is machine-readable, freely shared, used and built on without restrictions.

The key things to remember about open data are:

  • #Availability and access#: the data must be available as a whole and at no more than a reasonable reproduction cost, preferably by downloading over the internet. The data must also be available in a convenient and modifiable form.
  • #Re-use and redistribution#: the data must be provided under terms that permit re-use and redistribution including the intermixing with other datasets.
  • #Universal participation#: everyone must be able to use, re-use and redistribute. There should be no discrimination against fields of endeavour or against persons or groups. For example, 'non-commercial' restrictions that would prevent 'commercial' use, or restrictions of use for certain purposes (e.g. only in education), are not allowed.
47222 records

COVID-19 and other drug product announcements until July 2023.

Record Modified: Sep 3, 2023
Record Released: Sep 1, 2023
Publisher: Health Canada
Formats: HTML
Keywords: drug product announcements COVID-19 vaccine announcements

Acts and regulations, Health Canada guidance documents and policies related to pharmaceutical drugs and medical devices. The Pharmaceutical Drugs Directorate …

Record Modified: Sep 3, 2023
Record Released: Sep 1, 2023
Publisher: Health Canada
Formats: HTML
Keywords: drug products legislation Food-and-Drug Regulations Food-and-Drugs Act interim orders notices canada gazette memorandum of understanding schedule f guidance documents policies pharmaceutical drugs safe ...

List of Health Canada information sheets covering topics related to drug products.

Record Modified: Sep 3, 2023
Record Released: Sep 1, 2023
Publisher: Health Canada
Formats: HTML
Keywords: fact sheets information sheets drug products prescription drugs prescription medicines pharmaceutical products

Health Canada fact sheets related to medical devices.

Record Modified: Sep 3, 2023
Record Released: Sep 1, 2023
Publisher: Health Canada
Formats: HTML
Keywords: fact sheets medical devices

Fees for regulatory activities related to human drugs (pharmaceutical and biological) are charged as per the Fees in Respect of …

Record Modified: Sep 3, 2023
Record Released: Sep 1, 2023
Publisher: Health Canada
Formats: HTML
Keywords: human drugs fees fees for regulatory-activities fees for human-drugs pharmaceutical-and-biological drugs drugs-and-medical-devices order

The guidance is intended to advise both internal and external stakeholders regarding the filing requirements for post market changes and …

Record Modified: Sep 3, 2023
Record Released: Sep 1, 2023
Publisher: Health Canada
Formats: HTML
Keywords: guidance document post-drug identification number DIN Changes post market changes filing requirements

This guidance document provides information on the regulatory requirements for when: a drug is not sold for 12 or more …

Record Modified: Sep 3, 2023
Record Released: Sep 1, 2023
Publisher: Health Canada
Formats: HTML
Keywords: Cancellation of DIN notification of discontinuation-of-sales

Drug Identification Numbers for Schedule C Drugs.

Record Modified: Sep 3, 2023
Record Released: Sep 1, 2023
Publisher: Health Canada
Formats: HTML
Keywords: guidance document drug DIN DIN for Schedule-C-Drugs radiopharmaceuticals and kits

General COVID-19 flexibilities for all disinfectant application/submission pathways.

Record Modified: Sep 3, 2023
Record Released: Sep 1, 2023
Publisher: Health Canada
Formats: HTML
Keywords: applying for DIN DIN for disinfectant-drug COVID-19 pandemic application flexibilities COVID-19 flexibilities disinfectant application/submission

Steps to select the applicable fee category, the proper application stream and the pathways used to seek an authorization for …

Record Modified: Sep 3, 2023
Record Released: Sep 1, 2023
Publisher: Health Canada
Formats: HTML
Keywords: applying for DIN DIN for disinfectant-drug COVID-19 pandemic application stream applicable fee category proper application stream authorization for disinfectant-product